ID   ACTN4_RAT               Reviewed;         911 AA.
AC   Q9QXQ0; Q6P786;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   02-OCT-2024, entry version 193.
DE   RecName: Full=Alpha-actinin-4 {ECO:0000305};
DE   AltName: Full=Non-muscle alpha-actinin 4 {ECO:0000305};
GN   Name=Actn4 {ECO:0000312|RGD:61816};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10673389; DOI=10.1006/bbrc.1999.2045;
RA   El-Husseini A.E.-D., Kwasnicka D., Yamada T., Hirohashi S., Vincent S.R.;
RT   "BERP, a novel ring finger protein, binds to alpha-actinin-4.";
RL   Biochem. Biophys. Res. Commun. 267:906-911(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH PDLIM2.
RX   PubMed=15505042; DOI=10.1167/iovs.04-0721;
RA   Torrado M., Senatorov V.V., Trivedi R., Fariss R.N., Tomarev S.I.;
RT   "Pdlim2, a novel PDZ-LIM domain protein, interacts with alpha-actinins and
RT   filamin A.";
RL   Invest. Ophthalmol. Vis. Sci. 45:3955-3963(2004).
RN   [4]
RP   IDENTIFICATION IN A COMPLEX WITH CASK; IQGAP1; MAGI2; NPHS1; SPTAN1 AND
RP   SPTBN1, IDENTIFICATION BY MASS SPECTROMETRY, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Renal glomerulus;
RX   PubMed=15994232; DOI=10.1073/pnas.0504166102;
RA   Lehtonen S., Ryan J.J., Kudlicka K., Iino N., Zhou H., Farquhar M.G.;
RT   "Cell junction-associated proteins IQGAP1, MAGI-2, CASK, spectrins, and
RT   alpha-actinin are components of the nephrin multiprotein complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:9814-9819(2005).
CC   -!- FUNCTION: F-actin cross-linking protein which is thought to anchor
CC       actin to a variety of intracellular structures. This is a bundling
CC       protein. Probably involved in vesicular trafficking via its association
CC       with the CART complex. The CART complex is necessary for efficient
CC       transferrin receptor recycling but not for EGFR degradation. Involved
CC       in tight junction assembly in epithelial cells probably through
CC       interaction with MICALL2. Links MICALL2 to the actin cytoskeleton and
CC       recruits it to the tight junctions. May also function as a
CC       transcriptional coactivator, stimulating transcription mediated by the
CC       nuclear hormone receptors PPARG and RARA. Association with IGSF8
CC       regulates the immune synapse formation and is required for efficient T-
CC       cell activation. {ECO:0000250|UniProtKB:O43707}.
CC   -!- SUBUNIT: Homodimer; antiparallel. Interacts with MAGI1 (By similarity).
CC       Interacts with MICALL2 (preferentially in opened conformation);
CC       stimulated by RAB13 activation (By similarity). Identified in a
CC       IGF2BP1-dependent mRNP granule complex containing untranslated mRNAs
CC       (By similarity). Component of the CART complex, at least composed of
CC       ACTN4, HGS/HRS, MYO5B and TRIM3 (By similarity). Binds TRIM3 at the N-
CC       terminus (By similarity). Interacts with PDLIM2 (PubMed:15505042).
CC       Identified in a complex with CASK, IQGAP1, MAGI2, NPHS1, SPTAN1 and
CC       SPTBN1 (PubMed:15994232). Interacts with PPARG and RARA (By
CC       similarity). Binds to VCL; this interaction triggers VCL conformational
CC       changes (By similarity). Interacts with SEPTIN14 (By similarity).
CC       Interacts with IGSF8 (By similarity). {ECO:0000250|UniProtKB:O43707,
CC       ECO:0000250|UniProtKB:P57780, ECO:0000269|PubMed:15505042,
CC       ECO:0000269|PubMed:15994232}.
CC   -!- INTERACTION:
CC       Q9QXQ0; P19357: Slc2a4; NbExp=3; IntAct=EBI-919056, EBI-915426;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43707}. Cytoplasm
CC       {ECO:0000250|UniProtKB:O43707}. Cell junction
CC       {ECO:0000250|UniProtKB:P57780}. Cytoplasm, cytoskeleton, stress fiber
CC       {ECO:0000250|UniProtKB:O43707}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:P57780}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs. Expressed in the perinuclear
CC       rim and manchette structure in early elongating spermatids during
CC       spermiogenesis (By similarity). {ECO:0000250|UniProtKB:O43707,
CC       ECO:0000250|UniProtKB:P57780}.
CC   -!- TISSUE SPECIFICITY: Expressed in the foot process layer of podocytes in
CC       the kidney glomerulus but not in tubules (at protein level).
CC       {ECO:0000269|PubMed:15994232}.
CC   -!- DOMAIN: Contains one Leu-Xaa-Xaa-Leu-Leu (LXXLL) motif that mediates
CC       interaction with nuclear receptors. {ECO:0000250|UniProtKB:O43707}.
CC   -!- SIMILARITY: Belongs to the alpha-actinin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF190909; AAF20064.1; -; mRNA.
DR   EMBL; BC061788; AAH61788.1; -; mRNA.
DR   PIR; JC7186; JC7186.
DR   RefSeq; NP_113863.2; NM_031675.2.
DR   AlphaFoldDB; Q9QXQ0; -.
DR   BMRB; Q9QXQ0; -.
DR   SMR; Q9QXQ0; -.
DR   BioGRID; 248895; 8.
DR   CORUM; Q9QXQ0; -.
DR   IntAct; Q9QXQ0; 4.
DR   MINT; Q9QXQ0; -.
DR   STRING; 10116.ENSRNOP00000027773; -.
DR   GlyGen; Q9QXQ0; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9QXQ0; -.
DR   PhosphoSitePlus; Q9QXQ0; -.
DR   jPOST; Q9QXQ0; -.
DR   PaxDb; 10116-ENSRNOP00000027773; -.
DR   Ensembl; ENSRNOT00055057604; ENSRNOP00055047496; ENSRNOG00055033301.
DR   Ensembl; ENSRNOT00060056298; ENSRNOP00060046503; ENSRNOG00060032369.
DR   Ensembl; ENSRNOT00065058504; ENSRNOP00065048153; ENSRNOG00065034058.
DR   GeneID; 63836; -.
DR   KEGG; rno:63836; -.
DR   UCSC; RGD:61816; rat.
DR   AGR; RGD:61816; -.
DR   CTD; 81; -.
DR   RGD; 61816; Actn4.
DR   VEuPathDB; HostDB:ENSRNOG00000020433; -.
DR   eggNOG; KOG0035; Eukaryota.
DR   InParanoid; Q9QXQ0; -.
DR   OrthoDB; 2872403at2759; -.
DR   PhylomeDB; Q9QXQ0; -.
DR   TreeFam; TF352676; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   PRO; PR:Q9QXQ0; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020433; Expressed in jejunum and 19 other cell types or tissues.
DR   ExpressionAtlas; Q9QXQ0; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; ISO:RGD.
DR   GO; GO:0030054; C:cell junction; IBA:GO_Central.
DR   GO; GO:0042995; C:cell projection; IBA:GO_Central.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; ISO:RGD.
DR   GO; GO:0030863; C:cortical cytoskeleton; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098871; C:postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0031143; C:pseudopodium; ISO:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0001725; C:stress fiber; IDA:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0051015; F:actin filament binding; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0016922; F:nuclear receptor binding; ISO:RGD.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; ISS:UniProtKB.
DR   GO; GO:0042974; F:nuclear retinoic acid receptor binding; ISO:RGD.
DR   GO; GO:0001882; F:nucleoside binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; ISO:RGD.
DR   GO; GO:0098973; F:structural constituent of postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0051017; P:actin filament bundle assembly; ISO:RGD.
DR   GO; GO:0070830; P:bicellular tight junction assembly; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0032835; P:glomerulus development; ISO:RGD.
DR   GO; GO:0055001; P:muscle cell development; IBA:GO_Central.
DR   GO; GO:1900025; P:negative regulation of substrate adhesion-dependent cell spreading; ISO:RGD.
DR   GO; GO:0035357; P:peroxisome proliferator activated receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0090521; P:podocyte cell migration; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0048549; P:positive regulation of pinocytosis; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:1902396; P:protein localization to bicellular tight junction; ISO:RGD.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0042981; P:regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0030050; P:vesicle transport along actin filament; ISO:RGD.
DR   CDD; cd21214; CH_ACTN_rpt1; 1.
DR   CDD; cd21216; CH_ACTN_rpt2; 1.
DR   CDD; cd00051; EFh; 1.
DR   CDD; cd00176; SPEC; 3.
DR   Gene3D; 1.20.58.60; -; 4.
DR   Gene3D; 1.10.418.10; Calponin-like domain; 2.
DR   Gene3D; 1.10.238.10; EF-hand; 2.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH_dom.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR014837; EF-hand_Ca_insen.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR002017; Spectrin_repeat.
DR   PANTHER; PTHR11915:SF425; ALPHA-ACTININ-4; 1.
DR   PANTHER; PTHR11915; SPECTRIN/FILAMIN RELATED CYTOSKELETAL PROTEIN; 1.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF08726; EFhand_Ca_insen; 1.
DR   Pfam; PF00435; Spectrin; 4.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM01184; efhand_Ca_insen; 1.
DR   SMART; SM00150; SPEC; 4.
DR   SUPFAM; SSF47576; Calponin-homology domain, CH-domain; 1.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   SUPFAM; SSF46966; Spectrin repeat; 4.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Calcium; Cell junction; Cytoplasm;
KW   Cytoskeleton; Metal-binding; Nucleus; Phosphoprotein; Protein transport;
KW   Reference proteome; Repeat; Transport.
FT   CHAIN           1..911
FT                   /note="Alpha-actinin-4"
FT                   /id="PRO_0000073443"
FT   DOMAIN          50..154
FT                   /note="Calponin-homology (CH) 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          163..269
FT                   /note="Calponin-homology (CH) 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REPEAT          293..403
FT                   /note="Spectrin 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          413..518
FT                   /note="Spectrin 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          528..639
FT                   /note="Spectrin 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          649..752
FT                   /note="Spectrin 4"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          765..800
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          806..841
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          1..269
FT                   /note="Actin-binding"
FT   REGION          12..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          12..26
FT                   /note="Interaction with VCL"
FT                   /evidence="ECO:0000250|UniProtKB:O43707"
FT   REGION          40..61
FT                   /note="Interaction with VCL"
FT                   /evidence="ECO:0000250|UniProtKB:O43707"
FT   REGION          108..126
FT                   /note="Interaction with VCL"
FT                   /evidence="ECO:0000250|UniProtKB:O43707"
FT   REGION          177..192
FT                   /note="Polyphosphoinositide (PIP2)-binding"
FT                   /evidence="ECO:0000255"
FT   REGION          736..911
FT                   /note="Mediates interaction with MICALL2"
FT                   /evidence="ECO:0000250|UniProtKB:P57780"
FT   MOTIF           84..88
FT                   /note="LXXLL motif"
FT                   /evidence="ECO:0000250|UniProtKB:O43707"
FT   BINDING         778
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         780
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         789
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   MOD_RES         31
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P12814"
FT   MOD_RES         114
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O43707"
FT   MOD_RES         214
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P12814"
FT   MOD_RES         249
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O43707"
FT   MOD_RES         592
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O43707"
FT   MOD_RES         625
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O43707"
FT   MOD_RES         696
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P12814"
FT   MOD_RES         779
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P57780"
FT   MOD_RES         859
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P57780"
FT   MOD_RES         909
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1P2"
FT   CONFLICT        250
FT                   /note="A -> G (in Ref. 1; AAF20064)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        406
FT                   /note="R -> P (in Ref. 1; AAF20064)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        792
FT                   /note="A -> G (in Ref. 1; AAF20064)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        837
FT                   /note="R -> K (in Ref. 1; AAF20064)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        850
FT                   /note="A -> G (in Ref. 1; AAF20064)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        864
FT                   /note="A -> V (in Ref. 1; AAF20064)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        869
FT                   /note="R -> K (in Ref. 1; AAF20064)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   911 AA;  104915 MW;  0C5FC2E43B5D8FD2 CRC64;
     MVDYHAANQA YQYGPSSGGN GTGGGGGMGD YMAQEDDWDR DLLLDPAWEK QQRKTFTAWC
     NSHLRKAGTQ IENIDEDFRD GLKLMLLLEV ISGERLPKPE RGKMRVHKIN NVNKALDFIA
     SKGVKLVSIG AEEIVDGNAK MTLGMIWTII LRFAIQDISV EETSAKEGLL LWCQRKTAPY
     KNVNVQNFHI SWKDGLAFNA LIHRHRPELI EYDKLRKDDP VTNLNNAFEV AEKYLDIPKM
     LDAEDIVNTA RPDEKAIMTY VSSFYHAFSG AQKAETAANR ICKVLAVNQE NEHLMEDYER
     LASDLLEWIR RTIPWLEDRV PQKTIQEMQQ KLEDFRDYRR VHKPPKVQEK CQLEINFNTL
     QTKLRLSNRP AFMPSEGRMV SDINNGWQHL EQAEKGYEEW LLNEIRRLER LDHLAEKFRQ
     KASIHEAWTD GKEAMLKHRD YETATLSDIK ALIRKHEAFE SDLAAHQDRV EQIAAIAQEL
     NELDYYDSHN VNTRCQKICD QWDNLGSLTH SRREALEKTE KQLETIDQLH LEYAKRAAPF
     NNWMESAMED LQDMFIVHTI EEIEGLISAH DQFKSTLPDA DREREAILAI HKEAQRIAES
     NHIKLSGSNP YTSVTPQIIN SKWEKVQQLV PKRDHALLEE QSKQQSNEHL RRQFASQANM
     VGPWIQTKME EIGRISIEMN GTLEDQLSHL KQYERSIVDY KPNLDLLEQQ HQLIQEALIF
     DNKHTNYTME HLRVGWEQLL TTIARTINEV ENQILTRDAK GISQEQMQEF RASFNHFDKD
     HGGALGPEEF KACLISLGYD VENDRQGDAE FNRIMSVVDP NHSGLVTFQA FIDFMSRETT
     DTDTADQVIA SFKVLAGDKN FITAEELRRE LPPDQAEYCI ARMAPYQGPD AAPGALDYKS
     FSTALYGESD L
//
